Cargando…

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People’s Republic of China

Invasive fungal infections (IFIs) require rapid diagnosis and treatment. A decision-analytic model was used to estimate total costs and survival associated with a diagnostic-driven (DD) or an empiric treatment approach in neutropenic patients with hematological malignancies receiving chemotherapy or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Ningying, Lesher, Beth, Liu, Qifa, Qin, Lei, Chen, Yixi, Gao, Xin, Earnshaw, Stephanie R, McDade, Cheryl L, Charbonneau, Claudie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913884/ https://www.ncbi.nlm.nih.gov/pubmed/27366099 http://dx.doi.org/10.2147/CEOR.S101015

Ejemplares similares

Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom
por: Earnshaw, Stephanie R., et al.
Publicado: (2022)

Erratum for Earnshaw et al., “Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom”
por: Earnshaw, Stephanie R., et al.
Publicado: (2022)

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People’s Republic of China
por: Lesher, Beth, et al.
Publicado: (2016)

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model
por: Wilson, Michele R, et al.
Publicado: (2017)

Health and Economic Impact of Routine Pediatric Pneumococcal Immunization Programs in Canada: A Retrospective Analysis
por: Wilson, Michele R., et al.
Publicado: (2020)

Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada
por: Wilson, Michele, et al.
Publicado: (2018)

Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
por: Drgona, L., et al.
Publicado: (2013)

Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
por: Earnshaw, Stephanie R, et al.
Publicado: (2012)

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
por: Miceli, Marisa H, et al.
Publicado: (2012)

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting
por: Kaskel, Peter, et al.
Publicado: (2007)

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
por: Torres, Antoni, et al.
Publicado: (2022)

Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”
por: Wilson, Michele R., et al.
Publicado: (2018)

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital
por: Lesher, Beth A, et al.
Publicado: (2015)

Emerging fungal infections in immunocompromised patients
por: Low, Chian-Yong, et al.
Publicado: (2011)

Fungal Fourniers Gangrene in an Immunocompromised Patient
por: Crowell, Winston, et al.
Publicado: (2015)

Cutaneous fungal infection in an immunocompromised host
por: Sotello, David, et al.
Publicado: (2017)

Tula Hantavirus Infection in Immunocompromised Host, Czech Republic
por: Zelená, Hana, et al.
Publicado: (2013)

Improving Cancer Gene Expression Data Quality through a TCGA Data-Driven Evaluation of Identifier Filtering
por: McDade, Kevin K., et al.
Publicado: (2015)

Cost-Effectiveness of Blood-Based Brain Biomarkers for Screening Adults with Mild Traumatic Brain Injury in the French Health Care Setting
por: Zimmer, Louise, et al.
Publicado: (2023)

Acute invasive fungal sinusitis in immunocompromised children
por: Kebudi, Rejin
Publicado: (2022)

1604. Cost-Effectiveness of Ceftazidime-Avibactam for Patients with Hospital-Acquired Pneumonia Caused by Multi-Drug Resistant Enterobacteriaceae or Pseudomonas in China
por: Furnback, Wesley, et al.
Publicado: (2020)

Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
por: Paramithiotis, Eustache, et al.
Publicado: (2022)

Economic Outcomes of Isavuconazole to Prevent Invasive Fungal Infection in Immunocompromised Adults: Initial Experience at an Academic Medical Center
por: Kowalewska, Christina A, et al.
Publicado: (2017)

Estimating the Clinical and Economic Impact of Maintaining use of 13-valent Pneumococcal Conjugate Vaccine (PCV13) in Mexico
por: Wasserman, Matt, et al.
Publicado: (2017)

Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3‐beta‐D‐glucan in immunocompromised patient suspected fungal infection
por: Susianti, Hani, et al.
Publicado: (2021)

Fungal Infections of the Ear in Immunocompromised Host: a Review
por: Viswanatha, Borlingegowda, et al.
Publicado: (2011)

Challenges in the Diagnosis of Invasive Fungal Infections in Immunocompromised Hosts
por: Antinori, Spinello, et al.
Publicado: (2018)

Radionuclide Imaging of Invasive Fungal Disease in Immunocompromised Hosts
por: Lawal, Ismaheel O., et al.
Publicado: (2021)

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
por: Kinch, Amelie, et al.
Publicado: (2022)

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany
por: Patel, Dipen A, et al.
Publicado: (2014)

Anaerobic Storage Completely Removes Suspected Fungal Pathogens but Increases Antibiotic Resistance Gene Levels in Swine Wastewater High in Sulfonamides
por: Zhao, Xinyue, et al.
Publicado: (2023)

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
por: Kongnakorn, Thitima, et al.
Publicado: (2019)

Budget Impact of Microbial Cell-Free DNA Testing Using the Karius(®) Test as an Alternative to Invasive Procedures in Immunocompromised Patients with Suspected Invasive Fungal Infections
por: MacIntyre, Ann T., et al.
Publicado: (2020)

Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

Legionella and the Prevention of Legionellosis
por: McDade, Joseph E.
Publicado: (2008)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Segue: Brief summaries of articles on pertinent emerging issues published elsewhere.
por: McDade, Joseph E.
Publicado: (2004)

Addressing the potential threat of bioterrorism--value added to an improved public health infrastructure.
por: McDade, J E
Publicado: (1999)

The Microbial Challenge: Human-Microbe Interactions
por: McDade, Joseph E.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_aftoi1tqt5cuqonr9q4ns5drvf